HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tahir Ali Chohan Selected Research

Therapeutics

3/2024A systematic review on understanding the mechanistic pathways and clinical aspects of natural CDK inhibitors on cancer progression.: Unlocking cellular and biochemical mechanisms.
1/2023Fabrication and employment of cobalt-doped yttrium iron garnets for the electrochemical analysis of anti-diabetic, metformin in serum of type 2 diabetes mellitus patients.
10/2019Impact of Pruritus on Sleep Quality of Hemodialysis Patients: A Systematic Review and Meta-Analysis.
11/2018An insight into the emerging role of cyclin-dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers.
1/2016Molecular simulation studies on the binding selectivity of 2-anilino-4-(thiazol-5-yl)-pyrimidines in complexes with CDK2 and CDK7.
1/2015Cyclin-dependent kinase-2 as a target for cancer therapy: progress in the development of CDK2 inhibitors as anti-cancer agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tahir Ali Chohan Research Topics

Disease

5Neoplasms (Cancer)
03/2024 - 01/2015
2Skin Neoplasms (Skin Cancer)
09/2022 - 07/2022
1Myeloproliferative Disorders (Myeloproliferative Disorder)
03/2024
1Inflammation (Inflammations)
11/2023
1COVID-19
10/2023
1Type 2 Diabetes Mellitus (MODY)
01/2023
1Diabetes Mellitus
01/2023
1Renal Insufficiency (Renal Failure)
08/2021
1Prostatic Neoplasms (Prostate Cancer)
08/2021
1Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2020
1Obesity
01/2020
1Insulin Resistance
01/2020
1Pruritus (Itching)
10/2019
1Chronic Renal Insufficiency
10/2019
1Hyperglycemia
01/2019
1Carcinogenesis
11/2018

Drug/Important Bio-Agent (IBA)

2Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2024 - 11/2018
2CyclinsIBA
03/2024 - 01/2015
2EnzymesIBA
03/2024 - 01/2019
2PhytochemicalsIBA
09/2022 - 07/2022
1Phosphotransferases (Kinase)IBA
03/2024
1gamma-sitosterol (beta-sitosterol)IBA
11/2023
1remdesivirIBA
10/2023
1COVID-19 VaccinesIBA
10/2023
1Oseltamivir (Tamiflu)FDA Link
10/2023
1YttriumIBA
01/2023
1Metformin (Glucophage)FDA LinkGeneric
01/2023
1CobaltIBA
01/2023
1IronIBA
01/2023
1anthraceneIBA
07/2022
1Indicators and Reagents (Reagents)IBA
08/2021
1CreatinineIBA
08/2021
1CarbonIBA
08/2021
1AntimonyIBA
08/2021
1Fluorouracil (Carac)FDA LinkGeneric
11/2020
1HesperidinIBA
01/2020
1Leptin ReceptorsIBA
01/2020
1FatsIBA
01/2020
1LeptinIBA
01/2020
1Orlistat (Xenical)FDA Link
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1AlloxanIBA
01/2019
1AntioxidantsIBA
01/2019
1Blood Glucose (Blood Sugar)IBA
01/2019
1FlavonoidsIBA
01/2019
1C-Reactive ProteinIBA
01/2019
1Lipase (Acid Lipase)FDA Link
01/2019
1AmylasesFDA Link
01/2019
1CarbohydratesIBA
01/2019
1LipidsIBA
01/2019
1taxifolinIBA
01/2019
1Cyclin-Dependent Kinase 2IBA
01/2016

Therapy/Procedure

6Therapeutics
03/2024 - 01/2015
1Electrodes (Electrode)
08/2021
1Renal Dialysis (Hemodialysis)
10/2019